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NUTRITIONAL STATUS AS ASSESSED BY BIOIMPEDANCE SPECTROSCOPY
IN HYPOKALEMIC VERSUS NORMOKALEMIC CAPD PATIENTS.
Somchai Yongsiri, Suriya Prongnamjai, Pakapan Dinchuthai,
Rachneeporn Cheunsuwan, Jiranuch Thammakumpee,
Siriporn Tangjaturonrasami, Nattaphon Annanon
Burapha University Hospital Chonburi THAILAND
Hypokalemia is a signiﬁcant problem in CAPD patients. The impact of
hypokalemia on treatment outcome was not known. The study objective
was to compare the nutritional status as measured by Multifrequency
bioimpedance spectroscopy (BIS) and quality of life between peritoneal
dialysis patients who has hypokalemia and normokalemia. There were
8 hypokalemic and 18 normokalemic PD patients in this study. BIS were
measured by BCM-body composition monitor (Fresenius medical care)
device, quality of life was measured by WHOQOL-BREF questionnaire.
Levene’s Test was used for comparison and po0.05 was considered as
statistically signiﬁcant. There was no difference in the co-morbidity,
dialysis adequacy, blood pressure and food intake between groups. The
quality of life between groups was not statistically difference. BIS showed
comparable lean tissue index (LTI), fat tissue index (FTI), urea distribution
volume and ECW/ICF water ratio. Patients in the normokalemic group had
a non-signiﬁcant higher percent OH/ECW than hypokalemic group.
Parameters Hypokalemic Normokalemic p-value
Charlson’s comorbidity index 8.25þ/-2.05 9.06þ/-2.54 0.442
Weekly Kt/V 2.06þ/-0.35 1.94þ/-0.41 0.525
LTI (kg/m2) 11.31þ/-5.34 12.51þ/-2.68 0.449
FTI (kg/m2) 11.95þ/-7.92 10.51þ/-4.70 0.567
Urea distribution (L) 28.30þ/-8.63 29.64þ/-4.92 0.618
ECW/ICW 1.04þ/-0.34 1.03þ/-0.12 0.909
OH/ECW (%) 13.19þ/-13.88 17.71þ/-10.04 0.363
In conclusion, nutritional status and quality of life were not statistically
different between CAPD patients who had hypokalemia or normokalemia.
http://dx.doi.org/10.1016/j.krcp.2012.04.603
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FAVORED SERUM ALBUMIN LEVEL AND ICF VOLUME AFTER USE OF 1.1%
AMINOACID BASED PERITONEAL DIALYSIS(PD) SOLUTION
Jong-woo Yoon, Myung-jin Choi, Ja-ryong Koo, Young-ki Lee, Jung-woo Noh
Hallym university hospital, Chuncheon, Gangwon-do, South Korea.
Aminoacid based PD solution (AAD) has been shown to induce positive
nitrogen balance and improve nutritional markers of malnourished
patients. But its effcets on body ﬂuid composition and various nutritional
markers are contradictory. Nutritional markers may inﬂuenced by patient’s
ECF volume status. So we evaluate effects of AAD on nutritional markers
and body composition by analysis using multi-frequency bioimpedance
analyzer. 35 PD patients(46months duration of CAPD) were prospectively
randomized to 17 AAD(Nutrineal, one time use/day) and 18 GD group(keep
their glucose based PD solution). After 3 months follow up, AAD group
showed marginally increased body weight and fat mass, decreased ECF
volume(12.4570.54L vs 12.1070.57L, p¼0.06), no changed ICF
volume(22.270.9L vs 22.370.9L, p40.05) and marginally increased
drainage volume(8.7770.76L vs 9.1270.83L, p¼0.09). AAD group also
showed favored several markers include nPCR(1.5970.07 vs 1.9870.08,
p¼0.00), BUN and albumin level (3.5470.11 vs 3.7470.11, p¼0.02).
Although serum albumin level was increased, correction with ECF
volume(albumin level X ECF volume) makes it no difference
(43.4572.13 vs 44.8072.28, p¼0.14). FurthermoreWalbumin vsWECF
showed negative correlation pattern(r¼-0.46, p¼0.07) that means serum
albumin change was inﬂuenced by ECF volume change. In conclusion, AAD
treatment improved markers of better nutritional status. However the
change in serum albumin level was inﬂuenced by patient’s ECF volume
status, which can partially explain contradictory effect of aminoacid based
PD solution on serum albumin level.
http://dx.doi.org/10.1016/j.krcp.2012.04.604
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RESOLUTION OF SYMPTOMATIC IMMOBILIZATION HYPERCALCEMIA (IH)
AFTER REHABILITATION EXERCISES IN A HEMODIALYSIS PATIENT
Sun Ae Yoon, Young Ok Kim, Yu Seon Yun
Department of Internal Medicine, Uijongbu St. Mary’s Hospital, The Catholic
University of Korea, School of Medicine, Seoul, Korea
The patient is a 76-year-old Korean female who had been thrice-weekly
hemodialysis for 3 months for ESRD attributable to diabetic nephropathy. She
presented to emergency room with decreased mentality. Before admission, she
had been bed-ridden status for 4 months due to poor general condition. Brain
CT and MRI showed negative ﬁndings. Serum calcium was 15.6 mg/dl, ionized
calcium 2.12 mmol/L, hypercalciuria (FECa 26.2%), and low serum levels of iPTH
(42.92 pg/ml) suggested non-parathyroidal hypercalcemia. Two weeks ago, her
serum calcium and phosphate level was 9.0 and 6.1 mg/dl, respectively and she
was receiving calcium acetate. An extensive workup failed to identify any
etiology of hypercalcemia. Hypercalcemia was temporarily ameliorated after
withdrawal calcium-containing phosphate binder and daily hemodialysis with
low calcium (Caþþ 1.25 mmol/L) dialysate but recurred one week later. Serum
calcium level was increased and reached to 12.2–13.5 mg/dl. Immobilization
hypercalcemia was considered after the exclusion of other discernible causes.
We decided to try rehabilitation exercises. Two weeks after passive range of
motion (ROM) exercise of joints and tilting table standing, serum calcium level
was decreased to below 10.5 mg/dl.
http://dx.doi.org/10.1016/j.krcp.2012.04.605
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IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS
Valerie Young, Linda Orazio, Sunil V Badve, Annerley Bates, David
W Johnson, Katrina L Campbell
Princess Alexandra Hospital, Brisbane, Queensland, Australia
The purpose of this study is to identify barriers related to achieving an
adequate protein intake, and predictors of protein-energy wasting (PEW) in
Peritoneal Dialysis (PD) patients.
This is a prospective observational study of prevalent patients receiving
PD in our facility. Data collection occurs at baseline and six months,
including renal-related morbidity, biochemistry, weight, nutritional status
(Subjective Global Assessment (SGA) and PEW criteria), energy and protein
intake (via diet history), social situation and support, appetite and quality
of life (EQ-5D). The following is a preliminary analysis of baseline
characteristics, using chi-square, Fisher’s exact test and t-test, against
protein intake less than or greater than the recommended 1.2 g/kg
adjusted body weight (ABW).
To date, 43 patients have been recruited, 56% (n¼24) are male, with
mean (SD) age 61 (12.3) years and BMI 28.5 (7.3) kg/m2. Of these, 16%
(n¼7) were assessed as malnourished (SGA B or C) and 93% (n¼40) met
one or more PEW criteria. Sixty percent (n¼26) failed to meet minimum
protein requirements 1.2 g protein/kg ABW (mean 1.08 (0.3) g protein/kg
ABW). Inadequate protein intake was related to reliance on social security
(p¼0.05), having a diminished appetite (p¼0.05) and lower reported
quality of life (health utility index) (p¼0.03). PEWwas related to decreased
mobility (p¼0.05), difﬁculties with self care (p¼0.001) and presence of
pain/discomfort (p¼0.01).
In conclusion, inadequate protein intake was present in a signiﬁcant
portion of the population. Barriers to adequate intake in this population
can include low income and appetite levels, which may concomitantly
impact on quality of life. Further work on recruiting participants and
longitudinal follow-up is currently underway to elucidate the impact of
this on patient outcomes.
http://dx.doi.org/10.1016/j.krcp.2012.04.606
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EFFECT OF HIGH SALT ON RENAL NKCC2 IN CYP4F2 TRANSGENIC MICE
Yanyan Zhao, Jingjing Wu, Guangrei Lai
Department of Clinical Genetics, Shengjing Hospital of China Medical
University, Shenyang, Liaoning, China
Cytochrome P450 4F2 (CYP4F2) catalyzes theo-hydroxylation of arachidonic
acid (AA) to 20-HETE.We previously generated a CYP4F2 transgenic (TG) mouse
model, and demonstrated that overexpressed CYP4F2 elevates 20-HETE
production and blood pressure in the TG mice, indicating 20-HETE plays a
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